Murine models with lineage-restricted expression of Sf3b1 mutation have enabled mechanistic and functional dissection of the role of SF3B1 in vivo (8, 9); however, these models are restricted by high operating cost that limits the availability of different cancer models, human-to-mouse disease heterogeneity, and difficulty in further genetic manipulation. This evidence concerns the gene SF3B1 and cancer.